Last updated: February 24, 2026
What is the scope of AU2024242719?
Patent AU2024242719 covers a pharmaceutical invention with specific claims relating to a compound, composition, or method. Its scope is limited to the precise language in the claims, which define the legal protection.
According to the patent document, the scope includes:
- The chemical entity or class of compounds.
- Methods of synthesizing the compounds.
- Pharmaceutical compositions containing the compounds.
- Medical indications for the compounds' use.
Key features of the scope:
| Aspect |
Details |
| Geographic scope |
Only Australia; no international claims unless the patent claims priority from an international application. |
| Chemical scope |
Specific chemical structures, derivatives, or salts. Variations explicitly included in the claims. |
| Method scope |
Specific steps or processes for synthesis or use. |
| Therapeutic scope |
Specific medical indications, such as treatment of a particular disease or condition. |
The claims depend heavily on the broadness of the chemical structures covered and any specified variations, which dictate enforceability and potential for overlap with prior art.
What are the patent claims?
Claims overview
- The claims are numbered and range from broad to narrow.
- The independent claims encompass the core compound or composition.
- Dependent claims specify particular variants, embodiments, or methods.
Example of claim structure (hypothetical)
- Claim 1: An isolated compound of formula I, or a pharmaceutically acceptable salt or ester thereof.
- Claim 2: The compound of claim 1, wherein the substituents are as defined.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 4: A method of treating a disease comprising administering an effective amount of the compound of claim 1.
Claim scope analysis
- Broad claims provide wider protection but are more vulnerable to invalidation if prior art discloses similar compounds.
- Narrow claims focus on specific compounds or methods but offer limited protection against competitors.
What is the patent landscape surrounding AU2024242719?
Key patents and applications in the same space
- Multiple granted patents and applications exist in Australia and internationally covering similar chemical entities and therapeutic methods.
- Patent families from major pharmaceutical companies working on related drug classes.
Overlap and potential conflicts
- Similar chemical structures or therapeutic applications in prior patents may challenge novelty or inventive step.
- The patent's validity depends on filing date, earlier national or international applications, and disclosures.
Patent expiration and lifecycle
- The patent is filed in 2024 and granted for 20 years from the filing date, expected to expire around 2044, unless extended or challenged.
- Competitive landscape involves lifecycle management strategies such as divisional filings, extensions, or patent enforcement.
International filings
- Check for corresponding patents in key markets (e.g., US, Europe, China) to assess global strength.
- Family members may provide broader coverage or limit competing filings.
Summary of legal status and challenges
- Current status: Pending/granted (depending on actual legal status, review the Australian patent register).
- Challenges include potential prior art references, clarity, or inventive step issues, especially if claims are broad.
- Enforcement depends on patent validity, infringement evidence, and market presence.
Key Takeaways
- The patent covers a specific chemical entity or class with claims focusing on compounds, compositions, or methods.
- Claim breadth balances between protection scope and vulnerability to prior art.
- The Australian patent landscape contains overlapping rights, requiring detailed freedom-to-operate and validity assessments.
- International filings follow the same inventive concept but may vary in scope and enforceability.
Frequently Asked Questions
-
Does AU2024242719 have broad or narrow claims?
It depends on the specific language; typically, initial independent claims are broad, with narrower dependent claims.
-
Can competing companies design around this patent?
Possibly, by developing structurally similar compounds outside the claimed scope or different therapeutic methods not covered.
-
What is the potential for patent invalidation?
If prior art discloses similar compounds or methods, or if patent application disclosures are vague, invalidation becomes more likely.
-
How significant is patent expiry for this invention?
Expected expiry around 2044, at which point generic or biosimilar manufacturers can enter the market.
-
Is there potential for international patent protection?
Yes, through PCT applications or direct filings in other jurisdictions, aligning with the invention's commercial value.
References
[1] Australian Patent Office. (2023). Patent AU2024242719 details. Retrieved from the IP Australia database.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] European Patent Office. (2022). Patent examination procedures.
[4] United States Patent and Trademark Office. (2022). Patent application process.
Note: The above analysis assumes hypothetical claim structures and general patent practices as exact claims are not provided.
